State of Alaska Department of Revenue’s Apellis Pharmaceuticals APLS Stock Holding History

State of Alaska Department of Revenue’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-50,562	Closed	-$2.03M	–	2176
2026 Q1	$2.03M	Buy	+50,562	New	+$1.09M	0.02%	697

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

State of Alaska Department of Revenue's APLS Position: Q2 2026 in Review

State of Alaska Department of Revenue sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 50,562 shares — an estimated $2.03M sold.

State of Alaska Department of Revenue first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $2.03M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

State of Alaska Department of Revenue reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
State of Alaska Department of Revenue sold 50,562 Apellis Pharmaceuticals shares in Q2 2026, an estimated $2.03M.
State of Alaska Department of Revenue first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
State of Alaska Department of Revenue's Apellis Pharmaceuticals position peaked at $2.03M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.